Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05639088 · ClinicalTrials.gov registry record · NA

Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes

A NA study of Type 1 Diabetes, sponsored by Virginia Commonwealth University.

Active
Registry status
NA
Development phase
109
Enrollment target
1
Study location

NCT05639088 is a NA study of Type 1 Diabetes that is active but no longer recruiting, run by Virginia Commonwealth University. The registered enrollment target is 109 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05639088, a NA study of Type 1 Diabetes, is active but no longer recruiting, sponsored by Virginia Commonwealth University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
109 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to evaluate a transition preparation program designed for adolescents and young adults (AYAs) with type 1 diabetes (T1D). This transition program will support AYAs as they prepare to transition from pediatric to adult endocrinology medical care and will also include a caregiver. Results from this study will inform clinical recommendations regarding self-management best practices for AYAs with T1D prior to transitioning to adult medical care.

Conditions Studied

Interventions

  • OTHER Educational materials
  • BEHAVIORAL Transition preparation program

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2023-08-24
Est. Completion 2026-12-31
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT05639088

The ClinicalTrials.gov registry entry for NCT05639088 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (87% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Educational materials is the first listed.

NCT05639088 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT05639088 about?

NCT05639088 is a clinical study titled "Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes". The purpose of this research study is to evaluate a transition preparation program designed for adolescents and young adults (AYAs) with type 1 diabetes (T1D). This transition program will support AYAs as they prepare to transition from pediatric to adult endocrinology medical care and will also inc...

What is the current status of trial NCT05639088?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 109 participants. The study started on 2023-08-24. Estimated completion is 2026-12-31.

What conditions does trial NCT05639088 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT05639088?

The interventions under investigation include: Educational materials (OTHER), Transition preparation program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05639088?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05639088 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.